These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24691150)

  • 21. Herpes zoster encephalomyelitis in a patient with rheumatoid arthritis treated with low dose methotrexate.
    Golden HE
    J Rheumatol; 1997 Dec; 24(12):2487-8. PubMed ID: 9415667
    [No Abstract]   [Full Text] [Related]  

  • 22. [A survey of the doses of methotrexate and salazosulfapyridine in Japanese patients with rheumatoid arthritis].
    Kawai S; Ochi T; Kondo H; Nishioka K; Nobuyuki N; Yoshino S
    Ryumachi; 2002 Feb; 42(1):76-9. PubMed ID: 11925910
    [No Abstract]   [Full Text] [Related]  

  • 23. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
    Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
    Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
    [No Abstract]   [Full Text] [Related]  

  • 24. Complications with low dose methotrexate in rheumatoid arthritis.
    Kalke S; Balakrishnan C; Mittal G; Mangat G; Joshi VR
    J Assoc Physicians India; 1997 Nov; 45(11):903-4. PubMed ID: 11229210
    [No Abstract]   [Full Text] [Related]  

  • 25. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methotrexate for therapy of rheumatoid arthritis].
    Suzuki Y; Wakabayashi T; Jackson K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():498-502. PubMed ID: 15799406
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methotrexate therapy for rheumatism and collagen diseases].
    Osone Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2002 Aug; 25(4):330-6. PubMed ID: 16646163
    [No Abstract]   [Full Text] [Related]  

  • 28. Moving the injectable methotrexate service closer to home: a practice development initiative.
    Fitzgerald P; Hale C
    Musculoskeletal Care; 2014 Sep; 12(3):182-9. PubMed ID: 24706412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of rheumatoid arthritis.
    Kaushik P; Kaushik R
    Am J Med; 2008 Jun; 121(6):e7; author reply e9-10. PubMed ID: 18501219
    [No Abstract]   [Full Text] [Related]  

  • 30. Rare side effects of subcutaneous methotrexate therapy.
    Kapoor S
    J Rheumatol; 2013 Feb; 40(2):205. PubMed ID: 23378498
    [No Abstract]   [Full Text] [Related]  

  • 31. Pausing paw proliferation.
    Schubert C
    Nat Med; 2003 Jun; 9(6):643. PubMed ID: 12778155
    [No Abstract]   [Full Text] [Related]  

  • 32. Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: comment on the article by van Ede et al.
    Morgan SL; Baggott JE; Alarcón GS; Koopman WJ
    Arthritis Rheum; 2002 May; 46(5):1413-4. PubMed ID: 12115259
    [No Abstract]   [Full Text] [Related]  

  • 33. Missing the obvious.
    Nuenninghoff DM
    J Rheumatol; 2009 Aug; 36(8):1833; author reply 1833. PubMed ID: 19671823
    [No Abstract]   [Full Text] [Related]  

  • 34. Improving pregnancy counseling for women with rheumatoid arthritis taking methotrexate.
    Neeman N; Aronson MD; Schulze JE; Shmerling RH
    Am J Med; 2009 Nov; 122(11):998-1000. PubMed ID: 19854323
    [No Abstract]   [Full Text] [Related]  

  • 35. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
    Bakker MF; Jacobs JW; Welsing PM; van der Werf JH; Linn-Rasker SP; van der Veen MJ; Lafeber FP; Bijlsma JW;
    Ann Rheum Dis; 2010 Oct; 69(10):1849-52. PubMed ID: 20511610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The initial results of the Metex Study].
    Braun J
    Krankenpfl J; 2005; 43(7-10):246-7. PubMed ID: 16515316
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of chronic polyarthritis with methotrexate 1994--a review].
    Rau R
    Z Rheumatol; 1994; 53(4):199-229. PubMed ID: 7975933
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluating the safety of self-injection of gold and methotrexate in patients with inflammatory arthritis.
    Mateo L; Romera M; Rozadilla A; Cintero MI
    J Rheumatol; 2000 Mar; 27(3):818. PubMed ID: 10743832
    [No Abstract]   [Full Text] [Related]  

  • 40. Endothelial function improves within 6 weeks of treatment with methotrexate or methotrexate in combination with a TNF-α inhibitor in rheumatoid arthritis patients.
    Hjeltnes G; Hollan I; Førre Ø; Wiik A; Lyberg T; Mikkelsen K; Agewall S
    Scand J Rheumatol; 2012 May; 41(3):240-2. PubMed ID: 22401496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.